SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042553
Filing Date
2019-11-12
Accepted
2019-11-12 07:32:13
Documents
71
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q urgn-10q_20190930.htm   iXBRL 10-Q 2365150
2 EX-31.1 urgn-ex311_8.htm EX-31.1 19234
3 EX-31.2 urgn-ex312_9.htm EX-31.2 19273
4 EX-32.1 urgn-ex321_6.htm EX-32.1 9742
5 EX-32.2 urgn-ex322_7.htm EX-32.2 9760
  Complete submission text file 0001564590-19-042553.txt   7298038

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA urgn-20190930.xsd EX-101.SCH 50799
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urgn-20190930_cal.xml EX-101.CAL 51310
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20190930_def.xml EX-101.DEF 129829
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20190930_lab.xml EX-101.LAB 379594
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20190930_pre.xml EX-101.PRE 279406
69 EXTRACTED XBRL INSTANCE DOCUMENT urgn-10q_20190930_htm.xml XML 1202955
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38079 | Film No.: 191206103
SIC: 2834 Pharmaceutical Preparations